Kamil Zielinski
Overview
Explore the profile of Kamil Zielinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maarse M, Seiffge D, Werring D, Boersma L, Aarnink E, Fierro N, et al.
JAMA Neurol
. 2024 Oct;
PMID: 39374446
Importance: Patients with atrial fibrillation (AF) who have ischemic stroke despite taking oral anticoagulation therapy (OAT) have a very high risk of recurrence. Left atrial appendage occlusion (LAAO) is a...
2.
Aarnink E, Maarse M, Fierro N, Mazzone P, Beneduce A, Tondo C, et al.
JACC Cardiovasc Interv
. 2024 May;
17(11):1311-1321.
PMID: 38795093
Background: Left atrial appendage occlusion (LAAO) provides mechanical cardioembolic protection for atrial fibrillation (AF) patients who cannot use oral anticoagulation therapy (OAT). Patients with a thrombotic event despite OAT are...
3.
Talaj J, Zielinski K, Bujacz A
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675044
Free drug concentration in the blood sera is crucial for its appropriate activity. Serum albumin, the universal blood carrier protein, is responsible for transporting drugs and releasing them into the...
4.
Zielinski K, Pracon R, Konka M, Kruk M, Kepka C, Trochimiuk P, et al.
Int J Environ Res Public Health
. 2022 Nov;
19(21).
PMID: 36360682
Background: Transcatheter left atrial appendage closure (LAAC) is performed in patients unsuitable for long-term anticoagulation, predominantly due to prior bleeding events. The study aimed to investigate the incidence and predictors...
5.
Warminski G, Urbanek P, Orczykowski M, Bodalski R, Kalinczuk L, Zielinski K, et al.
Kardiol Pol
. 2022 Aug;
80(11):1104-1111.
PMID: 35950547
Background: Left atrial enlargement (LAE) predicts atrial fibrillation (AF) recurrence after cryoballoon-based pulmonary vein isolation (CB). Increased left ventricular wall thickness (LVWT) is pathophysiologically associated with LAE and atrial arrhythmias....
6.
Pracon R, Zielinski K, Bangalore S, Konka M, Kruk M, Kepka C, et al.
Int J Cardiol
. 2022 Feb;
354:17-21.
PMID: 35219744
Background: Patients with atrial fibrillation (AF) and oral anticoagulation (OAC) failure may benefit from left atrial appendage closure (LAAC), however, the evidence is scarce. We report outcomes of LAAC in...
7.
Kalinczuk L, Mintz G, Zielinski K, Dabrowski M, Witkowski A
JACC Cardiovasc Interv
. 2022 Feb;
15(6):e61-e62.
PMID: 35219620
No abstract available.
8.
Krzewska M, Dubas E, Golebiowska G, Nowicka A, Janas A, Zielinski K, et al.
Sci Rep
. 2021 Nov;
11(1):22215.
PMID: 34782682
Effective microspore embryogenesis (ME) requires substantial modifications in gene expression pattern, followed by changes in the cell proteome and its metabolism. Recent studies have awakened also interest in the role...
9.
Kalinczuk L, Zielinski K, Mintz G, Szymanski J, Sobieszczanska-Malek M, Kusmierczyk M, et al.
Kardiol Pol
. 2021 Nov;
79(12):1387-1388.
PMID: 34729734
No abstract available.
10.
Koltowski L, Tomaniak M, Ochijewicz D, Zielinski K, Proniewska K, Malinowski K, et al.
Am J Cardiol
. 2021 Jul;
155:23-31.
PMID: 34315572
Data on long-term neointimal healing and neoatherosclerosis progression after primary percutaneous coronary intervention (PCI) with implantation of everolimus-eluting bioresorbable vascular scaffold (BVS) (ABSORB BVS 1.0, Abbott Vascular) are limited. The...